Related Experiment Video
Updated: Aug 5, 2026

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
Harnessing Exhaled Breath for Lung Cancer Early Detection-Results From the ExPeL Study
Danita Kasi Patel1, Leon D'Cruz2,3, Waqar Ahmed4
1Manchester Institute of Biotechnology (MIB), Department of Chemistry, University of Manchester, Manchester, UK.
A new breath test, Inflammacheck, shows promise for early lung cancer detection. This non-invasive tool accurately identifies cancer using exhaled hydrogen peroxide and machine learning in screening populations.
Area of Science:
- Pulmonology
- Oncology
- Biochemistry
Background:
- Early lung cancer detection is crucial for improving patient outcomes and survival rates.
- Current diagnostic methods can be invasive or lack sufficient sensitivity for early-stage disease.
- There is a need for scalable, non-invasive tools to aid in early lung cancer detection and optimize referral pathways.
Purpose of the Study:
- To evaluate the Inflammacheck point-of-care device for non-invasive lung cancer detection using exhaled breath condensate (EBC).
- To assess the utility of EBC hydrogen peroxide (H2O2) and physiological parameters combined with machine learning in a real-world screening population.
- To compare machine learning model performance with untargeted LC-MS metabolomics for cancer discrimination.
Main Methods:
- The Exhaled Hydrogen Peroxide for Early Lung Cancer Detection (ExPeL) study enrolled participants from the UK Targeted Lung Health Check (TLHC) programme.
- Exhaled breath condensate (EBC) was collected using Inflammacheck, measuring H2O2, CO2, humidity, temperature, and flow rate.
- Multivariate analyses (PCA, LDA, Mahalanobis) and supervised machine learning models (stacked and voting ensembles) were employed, alongside LC-MS metabolomics.
Main Results:
- The voting ensemble model achieved 85.7% accuracy, 80% sensitivity, 100% specificity, and a 0.90 ROC-AUC, with no false positives.
- Multivariate analysis demonstrated clear separation between lung cancer patients and controls.
- Untargeted metabolomics identified key metabolites with an AUC of 0.969 for cancer discrimination.
Conclusions:
- Inflammacheck provides an effective, rapid, and non-invasive breath test for distinguishing early-stage lung cancer.
- The findings are highly relevant for primary care and screening triage, addressing challenges of non-specific symptoms and low prevalence.
- This technology offers a promising tool to enhance early lung cancer detection strategies.
More Related Videos
08:23Real-time Breath Analysis by Using Secondary Nanoelectrospray Ionization Coupled to High Resolution Mass Spectrometry
Published on: March 9, 2018
07:09Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
Published on: February 20, 2017
Related Concept Videos
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...